Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24/4 regimen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Hepatotoxicity induced by a second-generation combined oral contraceptive: case report and review of the literature

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. European society of contraception statement on contraception in obese women

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Sexual and reproductive health and HIV in border districts affected by migration and poverty in Tanzania

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Effekt af behandling med liraglutid på kardiovaskulære biomarkører hos kvinder med PCOS

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  2. Within-day energy deficiency and reproductive function in female endurance athletes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Ingrid J M Duijkers
  • Doris Heger-Mahn
  • Dominique Drouin
  • Sven Skouby
Vis graf over relationer

Objectives Progestogen-only pills (POPs) are safer with respect to cardiovascular risks than contraceptives containing estrogens. Despite the increased contraceptive efficacy of a desogestrel-only pill compared with a traditional POP, POPs are still not widely used due to an unpredictable bleeding pattern. A new POP containing 4 mg drospirenone has been developed with a 24/4 intake regimen which may improve the bleeding pattern. The objectives of this study were to investigate ovulation inhibition with the new drospirenone-only pill in comparison with the desogestrel-only pill and, in addition, to assess the effects on cervical mucus permeability and bleeding. Methods Sixty-four healthy volunteers with proven ovulatory cycles were randomised and treated with either the drospirenone-only or the desogestrel-only pill during two 28-day cycles. Follicular diameter, endometrial thickness, and serum estradiol (E2) and progesterone concentrations were measured and Hoogland scores were determined. Additionally, cervical mucus scores, bleeding and return of ovulation were assessed. Results Both treatments effectively inhibited ovulation. Follicular diameter, E2 levels and Hoogland scores were equal, demonstrating efficient ovarian suppression. One subject in each group had a Hoogland score of 6, but the criteria for normal luteal activity were not fulfilled. In both groups, ovulation did not occur before day 9 of the post-treatment cycle. Cervical mucus permeability was suppressed in both groups. The median number of bleeding and spotting days was lower in the drospirenone group. Conclusions The new drospirenone-only pill inhibited ovulation as effectively as the desogestrel-only pill despite the 4-day hormone-free interval. Chinese Abstract ,。,,,。4,24/4。,,。 64,28。、、,Hoogland。,、。 。、Hoogland,。Hoogland6,。9,。。,。 4,。 ;;;;;.

OriginalsprogEngelsk
TidsskriftThe European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Vol/bind20
Udgave nummer6
Sider (fra-til)419-27
Antal sider9
ISSN1362-5187
DOI
StatusUdgivet - dec. 2015

ID: 45718724